Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Home-based exercise program for kidney transplant recipients

Official title: A Home-based Exercise and Physical Activity Intervention After Kidney Transplantation: Impact of Exercise Intensity - a Multicenter Randomized Controlled Trial

Run by KU Leuven · NCT06260579 · Data updated 2026-11-12

This study is testing whether a home-based exercise program can help kidney transplant recipients improve their fitness and overall health compared to different levels of exercise intensity.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment147 (estimated)
SponsorKU Leuven
Academic / other
Locations2 sites (Ghent and 1 other locations)
StatusRecruiting
StartedNovember 14, 2022
Main results expectedSeptember 30, 2025
Study endsDecember 2029
Registry record updatedFebruary 15, 2024
Trial IDNCT06260579 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adult de novo kidney transplant recipients who are physically able to participate in an exercise program.

Probably not a fit

Patients with uncontrolled hypertension, uncontrolled diabetes, severe pulmonary disease, or other serious health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicentre randomized controlled trial evaluates the effectiveness and cost-effectiveness of a home-based exercise and physical activity intervention for de novo kidney transplant recipients. Participants will be randomly assigned to one of three groups: a low-intensity training group, a moderate-intensity training group, or a moderate- and high-intensity training group. The study aims to improve physical fitness, cardiovascular health, gut microbiome characteristics, and health-related quality of life over a six-month period. Following the intervention, a maintenance phase will promote a physically active lifestyle for participants in the moderate-intensity groups.

Why it matters

Potential benefit: If successful, this intervention could significantly enhance the physical fitness and overall health of kidney transplant recipients, potentially reducing their cardiovascular risk.

How similar studies have gone: Previous studies have shown positive outcomes with exercise interventions in transplant populations, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

De novo adult KTRs

Exclusion Criteria:

* Underlying heart disease, defined as aberrant CPET, unstable angina, non-revascularized lesions or life-threatening arrhythmias
* Uncontrolled hypertension
* Uncontrolled diabetes, defined as HbA1c ≥ 9%
* Musculoskeletal disorders not allowing physical training on a cycle ergometer, or any other medical reasons by the physician considered to be a contraindication for moderate or high-intensity physical exercise
* Multi-organ transplantation
* Ongoing treatment for malignancies
* Unable to understand Dutch
* No access to smartphone and/or computer with internet access
* Severe pulmonary disease defined as either forced vital capacity (FVC) \<50%, one-second value (FEV1) \<50%, or a diffusing capacity for carbon monoxide (DLCO) \<40% that excludes all serious underlying respiratory disease (pulmonary fibrosis, COPD GOLD II-IV, PAH).

Where it's running

  • UZ Ghent
    Ghent, Belgium
    Recruiting
  • UZ Leuven
    Leuven, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.